472 related articles for article (PubMed ID: 32771023)
1. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
[TBL] [Abstract][Full Text] [Related]
2. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
3. Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma.
Zhou J; Toh SH; Tan TK; Balan K; Lim JQ; Tan TZ; Xiong S; Jia Y; Ng SB; Peng Y; Jeyasekharan AD; Fan S; Lim ST; Ong CJ; Ong CK; Sanda T; Chng WJ
Mol Cancer; 2023 Apr; 22(1):69. PubMed ID: 37032358
[TBL] [Abstract][Full Text] [Related]
4. The RCAN1.4-calcineurin/NFAT signaling pathway is essential for hypoxic adaption of intervertebral discs.
Huang B; He Y; Li S; Wei X; Liu J; Shan Z; Huang Y; Chen J; Zhao F
Exp Mol Med; 2020 May; 52(5):865-875. PubMed ID: 32467610
[TBL] [Abstract][Full Text] [Related]
5. Aberrant super-enhancer-driven oncogene ENC1 promotes the radio-resistance of breast carcinoma.
Li L; Wang N; Zhu M; Xiong Y; Wang F; Guo G; Wang X; Gu Y
Cell Death Dis; 2021 Aug; 12(8):777. PubMed ID: 34362881
[TBL] [Abstract][Full Text] [Related]
6. FUN14 domain-containing 1 promotes breast cancer proliferation and migration by activating calcium-NFATC1-BMI1 axis.
Wu L; Zhang D; Zhou L; Pei Y; Zhuang Y; Cui W; Chen J
EBioMedicine; 2019 Mar; 41():384-394. PubMed ID: 30803933
[TBL] [Abstract][Full Text] [Related]
7. KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma.
Cai H; Liang J; Jiang Y; Wang Z; Li H; Wang W; Wang C; Hou J
J Exp Clin Cancer Res; 2024 Mar; 43(1):69. PubMed ID: 38443991
[TBL] [Abstract][Full Text] [Related]
8. Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling.
Pan XY; You HM; Wang L; Bi YH; Yang Y; Meng HW; Meng XM; Ma TT; Huang C; Li J
Theranostics; 2019; 9(15):4308-4323. PubMed ID: 31285763
[No Abstract] [Full Text] [Related]
9. Alternatively Constructed Estrogen Receptor Alpha-Driven Super-Enhancers Result in Similar Gene Expression in Breast and Endometrial Cell Lines.
Bojcsuk D; Nagy G; Bálint BL
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120995
[TBL] [Abstract][Full Text] [Related]
10. Regulator of calcineurin 1 controls growth plasticity of adult pancreas.
Gurda GT; Crozier SJ; Ji B; Ernst SA; Logsdon CD; Rothermel BA; Williams JA
Gastroenterology; 2010 Aug; 139(2):609-19, 619.e1-6. PubMed ID: 20438729
[TBL] [Abstract][Full Text] [Related]
11. The CCAAT/enhancer binding protein beta (C/EBPbeta) cooperates with NFAT to control expression of the calcineurin regulatory protein RCAN1-4.
Oh M; Dey A; Gerard RD; Hill JA; Rothermel BA
J Biol Chem; 2010 May; 285(22):16623-31. PubMed ID: 20371871
[TBL] [Abstract][Full Text] [Related]
12. MiR-600 mediates EZH2/RUNX3 signal axis to modulate breast cancer cell viability and sorafenib sensitivity.
Zhao Q; Li D; Feng J; Jinsihan D
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23613. PubMed ID: 38229326
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
Sun WM; Tao W; Li JC; Zhu DM; Miao Y
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
[TBL] [Abstract][Full Text] [Related]
14. Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.
Chen L; Jenjaroenpun P; Pillai AM; Ivshina AV; Ow GS; Efthimios M; Zhiqun T; Tan TZ; Lee SC; Rogers K; Ward JM; Mori S; Adams DJ; Jenkins NA; Copeland NG; Ban KH; Kuznetsov VA; Thiery JP
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2215-E2224. PubMed ID: 28251929
[TBL] [Abstract][Full Text] [Related]
15. RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma.
Song Z; Cao Q; Ruan H; Yang H; Wang K; Bao L; Cheng G; Xu T; Xiao H; Wang C; Liu D; Chen K; Zhang X
Exp Cell Res; 2018 Nov; 372(2):118-128. PubMed ID: 30267660
[TBL] [Abstract][Full Text] [Related]
16. Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.
Zuber V; Bettella F; Witoelar A; ; ; ; ; Andreassen OA; Mills IG; Urbanucci A
BMC Genomics; 2017 Mar; 18(1):270. PubMed ID: 28359301
[TBL] [Abstract][Full Text] [Related]
17. A hidden incoherent switch regulates RCAN1 in the calcineurin-NFAT signaling network.
Shin SY; Yang HW; Kim JR; Heo WD; Cho KH
J Cell Sci; 2011 Jan; 124(Pt 1):82-90. PubMed ID: 21172821
[TBL] [Abstract][Full Text] [Related]
18. The competing endogenous circular RNA ADAMTS14 suppressed hepatocellular carcinoma progression through regulating microRNA-572/regulator of calcineurin 1.
Song C; Li D; Liu H; Sun H; Liu Z; Zhang L; Hu Y
J Cell Physiol; 2019 Mar; 234(3):2460-2470. PubMed ID: 30317540
[TBL] [Abstract][Full Text] [Related]
19. ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.
Xie Y; Gou Q; Xie K; Wang Z; Wang Y; Zheng H
Oncotarget; 2016 Sep; 7(38):61273-61283. PubMed ID: 27542224
[TBL] [Abstract][Full Text] [Related]
20. The miR-1185-2-3p-GOLPH3L pathway promotes glucose metabolism in breast cancer by stabilizing p53-induced SERPINE1.
Xu Y; Chen W; Liang J; Zeng X; Ji K; Zhou J; Liao S; Wu J; Xing K; He Z; Yang Y; Liu Q; Zhu P; Liu Y; Li L; Liu M; Chen W; Huang W
J Exp Clin Cancer Res; 2021 Jan; 40(1):47. PubMed ID: 33509226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
